ReviewInternational journal of nanomedicine2026
Advances and Challenges in 3D Bioprinting of Cartilage Organoids: From Material Innovation to Functional Regeneration.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Three-Dimensional Bioprinting in Reconstructive Plastic Surgery: A Comprehensive Review.Cells · 2026Review
- Construction of Vascularized Intestinal Organoids Based on Scaffolds, Hydrogels, and 3D Printing Technologies and Their Applications in Drug Delivery.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Articular cartilage injury and degenerative disorders are major contributors to joint dysfunction. Because cartilage is avascular and aneural, its intrinsic healing capacity is extremely limited, which continues to present a major clinical challenge. Cartilage organoids, defined as three-dimensional constructs that recapitulate key structural, cellular, and functional features of native cartilage tissue, including cell-cell and cell-matrix interactions, zonal organization, and responsiveness to biochemical and mechanical cues, have emerged as promising platforms for cartilage regeneration and disease research. In this context, three-dimensional (3D) bioprinting offers a powerful top-down strategy for fabricating such organoids with high spatial precision, complementing conventional bottom-up self-assembly approaches. This capability has opened new opportunities for the generation of cartilage constructs with complex architectures and biomimetic functions, highlighting their potential in personalized therapy, disease modeling, and regenerative medicine. This review provides a comprehensive overview of recent progress in 3D bioprinting for cartilage organoid engineering. First, it summarizes advances in bioink design, ranging from natural and synthetic hydrogels to composite and reinforced systems, such as the emerging attapulgite-polyvinyl alcohol platform, as well as stimulus-responsive smart materials. These materials are being developed to better replicate the biochemical and mechanical properties of the native extracellular matrix while maintaining suitable printability. Second, the review discusses the principles, optimization strategies, and application characteristics of major bioprinting techniques, including extrusion-based, photocuring-based, inkjet, and microfluidic bioprinting, with particular emphasis on balancing printing fidelity, structural complexity, and cell viability. In addition, it examines key strategies for promoting functional maturation and in vivo integration of cartilage organoids, including coculture systems, direct vascularization approaches, spatiotemporally controlled delivery of growth factors, dynamic mechanical stimulation, and emerging osteoimmunomodulatory interventions such as macrophage polarization and neutrophil extracellular trap clearance. Despite substantial advances, several critical challenges remain, including limited biomimetic accuracy in hierarchical architecture, instability of long-term cell phenotype, difficulties in vascularizing large-scale constructs, and the absence of standardized criteria for clinical translation. By identifying these bottlenecks and outlining future directions, including the development of 4D bioprinting materials and the integration of organ-on-a-chip systems with artificial intelligence-based optimization, this review aims to support the evolution of cartilage organoids from structural mimics toward truly functional regenerative constructs, ultimately facilitating their translation into clinically applicable therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.